Medifast (MED) Gross Margin (2016 - 2025)
Historic Gross Margin for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to 69.43%.
- Medifast's Gross Margin fell 47000.0% to 69.43% in Q4 2025 from the same period last year, while for Dec 2025 it was 71.33%, marking a year-over-year decrease of 24700.0%. This contributed to the annual value of 71.33% for FY2025, which is 24700.0% down from last year.
- According to the latest figures from Q4 2025, Medifast's Gross Margin is 69.43%, which was down 47000.0% from 69.52% recorded in Q3 2025.
- In the past 5 years, Medifast's Gross Margin ranged from a high of 75.39% in Q3 2024 and a low of 69.27% during Q4 2022
- Moreover, its 5-year median value for Gross Margin was 72.82% (2024), whereas its average is 72.57%.
- Per our database at Business Quant, Medifast's Gross Margin soared by 47400bps in 2023 and then plummeted by -58700bps in 2025.
- Medifast's Gross Margin (Quarter) stood at 73.65% in 2021, then fell by -6bps to 69.27% in 2022, then rose by 7bps to 74.01% in 2023, then rose by 0bps to 74.13% in 2024, then decreased by -6bps to 69.43% in 2025.
- Its Gross Margin stands at 69.43% for Q4 2025, versus 69.52% for Q3 2025 and 72.61% for Q2 2025.